Patent intelligence · Companies
Company patent strength
Data as of 13 Oct 2026Methodology
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead - toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. A filer's full profile - inventors, filing trend and quality index - comes with Technical Insights. See plans. See how we rank.
Why this page exists - and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space - open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
1,051 domestic filers with 5+ patents · page 2 · the top 500 are listed
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 51 | COROMANDEL INTERNATIONAL | 74 | 3344.6% | 4 | 37 | 2016 - 2025 |
| 52 | CEAT | 73 | 2534.2% | 0 | 48 | 2017 - 2024 |
| 53 | BAJAJ ELECTRICALS | 72 | 1723.6% | 0 | 55 | 2017 - 2024 |
| 54 | PI INDUSTRIES | 72 | 1926.4% | 1 | 52 | 2019 - 2026 |
| 55 | TITAN | 72 | 3244.4% | 0 | 40 | 2017 - 2024 |
| 56 | ARCHANA | 70 | 00% | 3 | 67 | 2022 - 2026 |
| 57 | ASHOK LEYLAND | 70 | 1318.6% | 0 | 57 | 2017 - 2026 |
| 58 | COGNIZANT TECHNOLOGY SOLUTIONS INDIA | 68 | 5073.5% | 2 | 16 | 2013 - 2024 |
| 59 | ETTRICK INNOVATIONS | 68 | 22.9% | 25 | 41 | 2016 - 2024 |
| 60 | SRF | 67 | 1116.4% | 2 | 54 | 2018 - 2024 |
| 61 | PADMINI VNA MECHATRONICS | 62 | 5182.3% | 0 | 11 | 2013 - 2025 |
| 62 | THE PRINCIPAL | 61 | 58.2% | 8 | 48 | 2022 - 2026 |
| 63 | BHARAT FORGE | 60 | 4270% | 0 | 18 | 2014 - 2024 |
| 64 | OPTIMUS DRUGS | 59 | 46.8% | 11 | 44 | 2017 - 2024 |
| 65 | ENGINEERS INDIA | 56 | 2137.5% | 0 | 35 | 2017 - 2026 |
| 66 | RAJDHANI PETROCHEMICALS | 56 | 2239.3% | 2 | 32 | 2020 - 2025 |
| 67 | SIMPLEENERGY | 56 | 1425% | 1 | 41 | 2021 - 2026 |
| 68 | ZEN TECHNOLOGIES | 55 | 3563.6% | 0 | 20 | 2010 - 2025 |
| 69 | CIPLA | 54 | 1222.2% | 5 | 37 | 2015 - 2025 |
| 70 | HINDALCO INDUSTRIES | 53 | 2037.7% | 0 | 33 | 2016 - 2024 |
| 71 | WISIG NETWORKS | 53 | 3056.6% | 1 | 22 | 2016 - 2025 |
| 72 | AKUMS DRUGS PHARMACEUTICALS | 52 | 611.5% | 3 | 43 | 2022 - 2025 |
| 73 | PREEYARIKA INNOVATIONS | 52 | 59.6% | 5 | 42 | 2021 - 2024 |
| 74 | BAJAJ AUTO | 51 | 3160.8% | 0 | 20 | 2013 - 2024 |
| 75 | BHARAT PETROLEUM | 50 | 2550% | 0 | 25 | 2015 - 2026 |
| 76 | GODREJ BOYCE MFG | 50 | 918% | 0 | 41 | 2019 - 2025 |
| 77 | LARSEN TOUBRO | 50 | 1122% | 0 | 39 | 2017 - 2026 |
| 78 | RIVER MOBILITY | 50 | 2448% | 2 | 24 | 2022 - 2026 |
| 79 | ZOHO | 50 | 918% | 1 | 40 | 2020 - 2026 |
| 80 | TEJAS NETWORKS | 49 | 2142.9% | 1 | 27 | 2011 - 2026 |
| 81 | ZF COMMERCIAL VEHICLE CONTROL SYSTEMS INDIA | 49 | 918.4% | 2 | 38 | 2018 - 2023 |
| 82 | FERTIS INDIA | 48 | 1225% | 7 | 29 | 2017 - 2026 |
| 83 | ULTRAVIOLETTE AUTOMOTIVE | 48 | 2143.8% | 2 | 25 | 2017 - 2025 |
| 84 | VARROC ENGINEERING | 48 | 2654.2% | 0 | 22 | 2017 - 2025 |
| 85 | TATA ELXSI | 46 | 2758.7% | 0 | 19 | 2015 - 2025 |
| 86 | BINU DENNIS | 45 | 3271.1% | 6 | 7 | 2019 - 2026 |
| 87 | MOREPEN LABORATORIES | 45 | 715.6% | 0 | 38 | 2018 - 2024 |
| 88 | NUMEROS MOTORS | 45 | 1431.1% | 1 | 30 | 2021 - 2024 |
| 89 | BERT LABS | 44 | 511.4% | 4 | 35 | 2018 - 2026 |
| 90 | LOG 9 MATERIALS SCIENTIFIC | 44 | 511.4% | 9 | 30 | 2018 - 2024 |
| 91 | DEPARTMENT OF BIOTECHNOLOGY | 43 | 2353.5% | 0 | 20 | 2011 - 2024 |
| 92 | IFB INDUSTRIES | 43 | 1432.6% | 2 | 27 | 2014 - 2026 |
| 93 | BIORAD MEDISYS | 42 | 716.7% | 0 | 35 | 2017 - 2025 |
| 94 | SHIVANI | 42 | 00% | 3 | 39 | 2022 - 2026 |
| 95 | ZENSAR TECHNOLOGIES | 42 | 3788.1% | 3 | 2 | 2016 - 2022 |
| 96 | ADVIK HI TECH | 41 | 2356.1% | 0 | 18 | 2014 - 2024 |
| 97 | ARVIND | 41 | 2253.7% | 0 | 19 | 2017 - 2026 |
| 98 | LOHIA | 41 | 2970.7% | 0 | 12 | 2015 - 2024 |
| 99 | NATCO PHARMA | 41 | 1126.8% | 2 | 28 | 2017 - 2026 |
| 100 | OPTIMUS PHARMA | 41 | 49.8% | 8 | 29 | 2018 - 2024 |
Educational institutes are excluded - see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy - directional, not advice; see methodology. Read the ranking methodology →
Patent coverage: 4,84,093 applications, 84.4% filed 2022 onward, 96% carry AI-generated technology tags. Earlier records, back to 2004, are largely granted cases, so pre-2022 years show survivors rather than full filing volume.